Bogart Wealth LLC’s AbbVie ABBV Stock Holding History

Bogart Wealth LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Buy	45,098 +2,706	+6%	+$582K	0.39%	60
2026 Q1	$9.22M	Buy	42,392 +38,099	+887%	+$8.45M	0.36%	65
2025 Q4	$981K	Buy	4,293 +487	+13%	+$111K	0.04%	130
2025 Q3	$881K	Sell	3,806 -37	-1%	-$7.54K	0.04%	133
2025 Q2	$713K	Sell	3,843 -180	-4%	-$33.5K	0.03%	142
2025 Q1	$843K	Sell	4,023 -192	-5%	-$37.3K	0.04%	131
2024 Q4	$749K	Buy	4,215 +495	+13%	+$91K	0.04%	135
2024 Q3	$735K	Sell	3,720 -85	-2%	-$15.9K	0.03%	136
2024 Q2	$653K	Sell	3,805 -998	-21%	-$165K	0.03%	134
2024 Q1	$875K	Sell	4,803 -55,008	-92%	-$9.48M	0.05%	122
2023 Q4	$9.27M	Sell	59,811 -1,064	-2%	-$155K	0.52%	44
2023 Q3	$9.07M	Sell	60,875 -89	-0.1%	-$13.1K	0.56%	40
2023 Q2	$8.21M	Buy	60,964 +628	+1%	+$92.1K	0.52%	43
2023 Q1	$9.62M	Sell	60,336 -12,413	-17%	-$1.9M	0.64%	32
2022 Q4	$11.8M	Buy	72,749 +4,395	+6%	+$674K	0.82%	23
2022 Q3	$9.17M	Buy	68,354 +10,388	+18%	+$1.49M	0.77%	22
2022 Q2	$8.88M	Buy	57,966 +9,262	+19%	+$1.42M	0.78%	24
2022 Q1	$7.9M	Sell	48,704 -8,484	-15%	-$1.23M	0.68%	22
2021 Q4	$7.74M	Buy	57,188 +2,581	+5%	+$305K	0.7%	20
2021 Q3	$5.89M	Buy	54,607 +2,996	+6%	+$342K	0.6%	22
2021 Q2	$5.81M	Buy	51,611 +6,234	+14%	+$702K	0.64%	19
2021 Q1	$4.91M	Buy	45,377 +10,386	+30%	+$1.11M	0.68%	20
2020 Q4	$3.75M	Buy	34,991 +1,919	+6%	+$184K	0.7%	22
2020 Q3	$2.9M	Sell	33,072 -646	-2%	-$60.8K	0.64%	25
2020 Q2	$3.31M	Sell	33,718 -171	-0.5%	-$15.1K	0.78%	20
2020 Q1	$2.58M	Sell	33,889 -2,049	-6%	-$175K	0.7%	23
2019 Q4	$3.18M	Buy	35,938 +748	+2%	+$62.1K	1.02%	14
2019 Q3	$2.67M	Buy	35,190 +1,998	+6%	+$137K	1.31%	18
2019 Q2	$2.41M	Buy	33,192 +4,123	+14%	+$324K	1.46%	22
2019 Q1	$2.34M	Buy	29,069 +6,823	+31%	+$558K	1.13%	18
2018 Q4	$2.05M	Buy	22,246 +627	+3%	+$55.1K	1.02%	14
2018 Q3	$2.04M	Buy	21,619 +1,834	+9%	+$174K	1.18%	17
2018 Q2	$1.83M	Buy	19,785 +783	+4%	+$76.5K	1.11%	17
2018 Q1	$1.75M	Buy	19,002 +1,315	+7%	+$144K	1.01%	20
2017 Q4	$1.71M	Sell	17,687 -5,914	-25%	-$557K	1.1%	17
2017 Q3	$2.14M	Sell	23,601 -838	-3%	-$63.8K	1.59%	7
2017 Q2	$1.77M	Buy	24,439 +6,491	+36%	+$436K	1.14%	14
2017 Q1	$1.17M	Buy	17,948 +1,528	+9%	+$96.1K	0.78%	20
2016 Q4	$1.03M	Buy	+16,420	New	+$1M	0.7%	25

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bogart Wealth LLC's ABBV Position: Q2 2026 in Review

Bogart Wealth LLC increased its AbbVie (ABBV) stake by 6.4% in Q2 2026, buying an estimated $582K and bringing the position to 45,098 shares worth $11.3M. The position accounts for 0.39% of the portfolio, ranked #60.

Bogart Wealth LLC first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $11.8M in Q4 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bogart Wealth LLC held 45,098 shares of AbbVie worth $11.3M as of Q2 2026.
Bogart Wealth LLC bought 2,706 AbbVie shares in Q2 2026, an estimated $582K.
AbbVie made up 0.39% of Bogart Wealth LLC's portfolio in Q2 2026, its #60 holding.
Bogart Wealth LLC first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
Bogart Wealth LLC's AbbVie position peaked at $11.8M in Q4 2022.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.